Phreesia (PHR) Insider Ramin Sayar Buys $185K of Stock
Ramin Sayar purchased 19,290 shares of Phreesia for $184,991 on June 24, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Ramin Sayar bought 19,290 shares of Phreesia, Inc. ($PHR) at an average price of $9.59, worth about $184,991.10, on June 24, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $PHR is up 11.8% after 1 week, up 6.6% after 1 month and up 14.1% to date (from the $9.59 close on Jun 24, 2026).
PHR
Phreesia, Inc.
Key Points
- Ramin Sayar bought 19,290 shares of Phreesia, Inc. at $9.59 each, totaling $184,991 on June 24, 2026.
- Phreesia, Inc. traded at $9.13 on Saturday with a market cap of $622.4 million and a P/E ratio of 62.9.
- Analysts have set price targets between $9 and $20, with a consensus rating of 'buy'.
Get $PHR trade alerts by text
We text you when insiders, Congress or big funds trade $PHR. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Phreesia, Inc. alert may contain errors. Disclosures
On June 24, 2026, Ramin Sayar made a significant move by purchasing 19,290 shares of Phreesia, Inc. (NYSE: PHR) at an average price of $9.59 per share. This transaction, totaling $184,991, was not part of a pre-arranged trading plan.
Insider Buying and Selling at Phreesia, Inc.
Several insiders at Phreesia, Inc. made notable transactions recently. On June 24, besides Ramin Sayar, other insiders such as Lainie Goldstein, Mark Douglas Smith, and Gillian Munson also acquired 19,290 shares each at the same price. These transactions were not planned trades. Additionally, Lisa Egbuonu-Davis sold 2,546 shares on June 25 under a planned transaction.
Phreesia, Inc. Stock Up 0.3%
Shares of Phreesia, Inc. traded near $9.13 on Saturday. The company boasts a market capitalization of approximately $622.4 million. With a P/E ratio of 62.9 and a forward P/E of 6.3, the stock reflects investor expectations for future growth. Phreesia's beta stands at 0.884, indicating its volatility relative to the market. Over the past year, the stock has seen a low of $7.77 and a high of $32.76. The company's 50-day moving average is $9.38, while the 200-day moving average is $15.21.
Analysts Set New Price Targets
Analysts have been active in setting new price targets for Phreesia. On May 29, Truist Securities maintained a 'hold' rating with a $12 target. Citigroup also maintained a 'hold' rating on May 28, while Canaccord Genuity and DA Davidson maintained their 'buy' ratings with targets of $16 and $14, respectively. Notably, Wells Fargo downgraded the stock to 'hold' on May 20 with a $9 target. Overall, the consensus recommendation is a 'buy', with a mean price target of $13.94.
About Phreesia, Inc.
Phreesia, Inc. is a healthcare technology company based in Wilmington, Delaware. Founded in 2005, it offers a SaaS-based platform providing various solutions for healthcare organizations in the U.S. and Canada. These include appointment optimization, payment solutions, and patient engagement tools. The company serves a diverse range of healthcare providers and organizations, aiming to improve operational efficiency and patient experience.
Bottom Line
Ramin Sayar's purchase of Phreesia shares underscores confidence in the company's growth potential. Investors often track insider transactions for insights into company prospects. While this filing provides a snapshot of insider activity, it's important to remember such trades are reported after they occur.
Related Filing Alerts
Source: Ramin Sayar's Form 4 filing on $PHR (Jun 24, 2026). Find the original filing: PHR Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts